Among the 552 mRNAs examined, ST6GAL2 (fold change = 2.29387, pvalue = 0.00005, qvalue = 0.005485) was dramatically up-regulated in advanced FTC (Fig. 1b,d). This evidence concerns the gene ST6GAL2 and thyroid cancer, nonmedullary, 2.